All In Biotech

Free tool

FAERS Monitor: Parnate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 012342 or its brand name (Parnate, Tranylcypromine Sulfate). Reports on generic versions are filed under their own applications.

Reports

804

Serious

501

62% of reports

Hospitalization

212

Death reported

40

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective95
  • depression91
  • drug interaction80
  • headache72
  • contraindicated product administered68
  • nausea63
  • insomnia61
  • hypertensive crisis60
  • anxiety51
  • dizziness50
  • hypertension50
  • suicidal ideation46
  • fatigue45
  • hyperhidrosis42
  • weight increased42

Reports by year received

View as table
YearReports
200448
200545
200653
200750
200859
200938
201039
201151
201227
201313
201412
201538
201644
201725
201829
201955
202030
202115
202221
202330
202440
202528
202614

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,355 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypertensive crisisSignal60141.8111.18,209
contraindicated product administeredSignal6858.946.93,808
drug interactionSignal8013.210.7896
suicidal ideationSignal4613.29.9506
depressionSignal9110.58.6778
hyperhidrosisSignal428.56.4273
hypertensionSignal506.24.7214
insomniaSignal616.04.7252
weight increasedSignal424.93.7128
anxietySignal514.73.6146
headacheSignal723.02.497
dizzinessSignal502.62.050
nauseaSignal632.11.636
drug ineffective951.91.641
fatigue451.51.18

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.